Medtronic's INFUSE Bone Graft and similar products from Zimmer Biomet and Stryker Corporation are significant contributors to this market growth. The development of synthetic bone graft materials ...

Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

Kuros Biosciences USA, Inc., a wholly owned subsidiary of Kuros Biosciences AG, has entered into a five-year, exclusive sales agency agreement with the Medtronic spinal division. Kuros is a ...

The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline ...

4, 2024 — Researchers have developed a revolutionary bone graft substitute inspired by coral which not only promotes faster healing but dissolves naturally in the body after the repair is ...

Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that it received CE mark approval for its BrainSense ...

Parkhill's exit came months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI ...

Medtronic India Pvt. Ltd. began operations in India in 1979. It is the wholly owned subsidiary of Medtronic Plc, an American Irish medical devices company. The company has presence across India in ...

Medtronic (NYSE: MDT) + announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical. Under the agreement, Medtronic serves as the sole U.S. distributor for ...